309 related articles for article (PubMed ID: 8381194)
1. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
4. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
[TBL] [Abstract][Full Text] [Related]
5. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
6. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
7. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 differentially modulates interleukin-4- and interleukin-2-induced human B cell growth.
Kimata H; Lindley I
Eur J Immunol; 1994 Dec; 24(12):3237-40. PubMed ID: 7805753
[TBL] [Abstract][Full Text] [Related]
11. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
[TBL] [Abstract][Full Text] [Related]
12. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
Jelinek DF; Lipsky PE
J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
[TBL] [Abstract][Full Text] [Related]
15. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
16. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
17. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
18. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
Lorré K; Fransen L; Ceuppens JL
Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
[TBL] [Abstract][Full Text] [Related]
20. Secretion of thioredoxin after in vitro activation of human B cells.
Ericson ML; Hörling J; Wendel-Hansen V; Holmgren A; Rosén A
Lymphokine Cytokine Res; 1992 Oct; 11(5):201-7. PubMed ID: 1334710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
